Vanda Pharmaceuticals Inc — Balance Sheet (NASDAQ:VNDA) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Total assets 533.46 M593.79 M634.25 M648.44 M656.2 M488.95 M Total liabilities 80.19 M88.86 M107.05 M103.53 M117.66 M161.76 M Total equity 453.27 M504.93 M527.2 M544.91 M538.55 M327.19 M Total liabilities & shareholders' equities 533.46 M593.79 M634.25 M648.44 M656.2 M488.95 M Total debt —————— Net debt ——————

新闻

FDA接受Vanda治疗罕见皮肤病药物imsidolimab的申请

Vanda Pharmaceuticals Breaks Through With FDA Approval, Decision Date For Skin Drug - Vanda Pharmaceuticals (NASDAQ:VNDA)

American Express, Oracle among market cap stock movers on Monday

H.C. Wainwright因FDA批准将Vanda Pharmaceuticals目标价上调至24美元

Vanda Pharmaceuticals stock price target raised to $24 by H.C. Wainwright on FDA approval

Why Is Vanda Pharmaceuticals Stock Soaring On Monday? - Vanda Pharmaceuticals (NASDAQ:VNDA)

Stock Market Today: Dow Jones, S&P 500 Futures Drop After Supreme Court Strikes Down Trump's Emergency Tariffs— Novo Nordisk, Strategy, Vanda In Focus - State Street SPDR S&P 500 ETF Trust (ARCA:SPY)

Vanda Pharmaceuticals stock surges after the FDA approves its new Bipolar I drug

FDA批准Vanda的Bysanti用于治疗双相情感障碍和精神分裂症

FDA approves Vanda’s Bysanti for bipolar disorder, schizophrenia

Vanda Pharmaceuticals Inc. (VNDA) Q4 2025 Earnings Call Transcript

万达制药2025年第四季度业绩未达预期